Mapping Interactions between Glycans and Glycan-Binding Proteins by Live Cell Proximity Tagging

Interactions between glycans and glycan-binding proteins (GBPs) consist of weak, noncovalent, and transient binding events, making them difficult to study in live cells void of a static, isolated system. Furthermore, the glycans are often presented as protein glycoconjugates, but there are limited e...

Full description

Bibliographic Details
Main Authors: Huang, M.L (Author), Joeh, E. (Author), Parker, C.G (Author), Reeves, A.E (Author)
Format: Article
Language:English
Published: Blackwell Publishing Inc. 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03971nam a2200745Ia 4500
001 10.1002-cpz1.104
008 220427s2021 CNT 000 0 und d
020 |a 26911299 (ISSN) 
245 1 0 |a Mapping Interactions between Glycans and Glycan-Binding Proteins by Live Cell Proximity Tagging 
260 0 |b Blackwell Publishing Inc.  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/cpz1.104 
520 3 |a Interactions between glycans and glycan-binding proteins (GBPs) consist of weak, noncovalent, and transient binding events, making them difficult to study in live cells void of a static, isolated system. Furthermore, the glycans are often presented as protein glycoconjugates, but there are limited efforts to identify these proteins. Proximity labeling permits covalent tagging of the glycoprotein interactors to query GBP in live cells. Coupled with high-resolution mass spectrometry, it facilitates determination of the proteins bearing the interacting glycans. In this method, fusion protein constructs of a GBP of interest with a peroxidase enzyme allows for in situ spatiotemporal radical-mediated tagging of interacting glycoproteins in living cells that can be enriched for identification. Using this method, the capture and study of glycan-GBP interactions no longer relies on weak, transient interactions, and results in robust capture and identification of the interactome of a GBP while preserving the native cellular environment. This protocol focuses on (1) expression and characterization of a recombinant fusion protein consisting of a peroxidase and the GBP galectin-3, (2) corresponding in situ labeling and visualization of interactors, (3) and proteomic workflow and analysis of captured proteins for robust identification using mass spectrometry. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Expression, purification, and characterization of recombinant fusion protein. Alternate Protocol 1: Manual Ni-NTA purification of recombinant fusion protein. Basic Protocol 2: In situ proximity labeling and evaluation by fluorescence microscopy. Alternate Protocol 2: Western blot analysis of in situ proximity labeling. Basic Protocol 3: Proximity labeling of cells for quantitative MS-based proteomics with tandem mass tags. © 2021 Wiley Periodicals LLC 
650 0 4 |a alkylation 
650 0 4 |a Article 
650 0 4 |a binding affinity 
650 0 4 |a carrier protein 
650 0 4 |a Carrier Proteins 
650 0 4 |a carrier proteins and binding proteins 
650 0 4 |a cells 
650 0 4 |a chemical labeling 
650 0 4 |a enzyme linked immunosorbent assay 
650 0 4 |a fluorescence microscopy 
650 0 4 |a fusion protein 
650 0 4 |a galectin 
650 0 4 |a galectin 3 
650 0 4 |a glycan 
650 0 4 |a glycan 
650 0 4 |a glycan binding protein 
650 0 4 |a glycoprotein 
650 0 4 |a Glycoproteins 
650 0 4 |a interactomics 
650 0 4 |a mass spectrometry 
650 0 4 |a Mass Spectrometry 
650 0 4 |a peroxidase 
650 0 4 |a plasmid 
650 0 4 |a polysaccharide 
650 0 4 |a Polysaccharides 
650 0 4 |a protein analysis 
650 0 4 |a protein binding 
650 0 4 |a protein denaturation 
650 0 4 |a protein expression 
650 0 4 |a protein interaction 
650 0 4 |a protein modification 
650 0 4 |a protein purification 
650 0 4 |a proteomics 
650 0 4 |a proteomics 
650 0 4 |a proteomics 
650 0 4 |a Proteomics 
650 0 4 |a proximity labeling 
650 0 4 |a quantitative analysis 
650 0 4 |a radical 
650 0 4 |a recombinant protein 
650 0 4 |a reduction (chemistry) 
650 0 4 |a standardization 
650 0 4 |a streptavidin 
650 0 4 |a TMT labeling 
650 0 4 |a trypsinization 
650 0 4 |a unclassified drug 
650 0 4 |a Western blotting 
650 0 4 |a workflow 
700 1 |a Huang, M.L.  |e author 
700 1 |a Joeh, E.  |e author 
700 1 |a Parker, C.G.  |e author 
700 1 |a Reeves, A.E.  |e author 
773 |t Current Protocols